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Abstract 
Rare diseases are very difficult to identify among large number of other possible diagnoses. Better availability of 
patient data and improvement in machine learning algorithms empower us to tackle this problem computationally. 
In this paper, we target one such rare disease – cardiac amyloidosis. We aim to automate the process of identifying 
potential cardiac amyloidosis patients with the help of machine learning algorithms and also learn most predictive 
factors. With the help of experienced cardiologists, we prepared a gold standard with 73 positive (cardiac 
amyloidosis) and 197 negative instances. We achieved high average cross-validation F1 score of 0.98 using an 
ensemble machine learning classifier. Some of the predictive variables were: Age and Diagnosis of cardiac arrest, 
chest pain, congestive heart failure, hypertension, prim open angle glaucoma, and shoulder arthritis. Further 
studies are needed to validate the accuracy of the system across an entire health system and its generalizability for 
other diseases. 
 
Introduction 
Because of several well-established factors such as a) subjectivity involved in human decision-making, b) domain 
knowledge, and c) prior experience,1,2 there is a possibility of type-1 and type-2 errors in identifying whether 
patients satisfy a known set of inclusion and exclusion criteria. Furthermore, clinicians typically rely on patterns 
learnt from patients encountered in their own settings, thereby missing out on the advantage of screening patients or 
diagnosing them based on latent knowledge and patterns present across an entire health system. An automated 
process for prescreening and early diagnosis would be quicker and serve as an independent judge. Rare or orphan 
diseases defined by the Rare Diseases Act of 2002 as diseases that affect fewer than 200,000 people in the United 
States (equivalent to approximately 6.5 patients per 10,000 inhabitants3) present a special case of this. There are 
about 8,000 rare diseases such as cardiac amyloidosis today and they appear early in life often proving to be fatal or 
chronically debilitating.4,5 Cardiac amyloidosis is caused by abnormal deposits of protein called amyloid in the heart 
tissue.6 These tissues make it hard for the heart to work properly. It is very difficult to successfully recognize a 
potential cardiac amyloidosis patient manually among large number of other patients. For enrolling rare disease 
patients for clinical trials, clinicians usually assign pre-defined constraints to filter out most negative patients. 
However, they still have to manually go through the remaining large part of each patient’s medical record to 
precisely arrive at a correct decision. For decision making, clinicians have a higher chance of missing the diagnosis 
of a rare disease since the symptoms are largely unknown for many rare diseases and such patients are encountered 
only a few times during normal care.  
The creation and adoption of electronic health records (EHRs) ignited widespread interest and created abundant 
opportunities for clinical and translational research.7 As Friedman et al noted, the extensive use of clinical data 
provides great potential to transform our healthcare system into a “Self-learning Health System.”8,9 In addition to its 
primary purpose of providing improved clinical practice, the use of EHRs offers means for the identification of 
participants who satisfy predefined criteria. This can be used for a variety of applications, including clinical trial 
recruitment, outcome prediction, survival analysis, and other retrospective studies.10-13 The overall goal of this 
research is to develop a platform that identifies patients potentially with any rare disease or has the risk of any risk 
disease. We are testing this approach initially on cardiac amyloidosis; however, our approach is scalable to all rare 
diseases. The main components of our platform are to represent each patient as a multidimensional vector and then 
to use machine-learning algorithms based on available data on rare diseases to automatically identify them.  
Methods 
Figure 1 describes the architecture of our approach. 
 
Figure 1: Architecture of our system. We first collect patient records from the Northwestern Medicine Enterprise 
Data Warehouse (NMEDW). Next, the important sections of patient records are extracted and transformed to obtain 
patient vectors. These vectors are then used to train machine learning algorithms which gives the final classification 
model and a list of top decisive features. 
First, we created a reasonable sized dataset of positive and negative cardiac amyloidosis patients using information 
from past and ongoing clinical trials of cardiac amyloidosis at Northwestern Medicine. A total of 73 cardiac 
amyloidosis patients were identified and formed the positive instances. A random sample of 197 patients that visited 
cardiologists at Northwestern Medicine but were not diagnosed to have cardiac amyloidosis (based on their ICD-9 
codes) formed the negative instances. The negative patients were chosen in such a way so as to maintain similarity 
with the positive patients but not have cardiac amyloidosis.  A total of 270 patients formed our training dataset as 
summarized in Table 1. 
Table 1. Number of instances in each category 
Positive cardiac amyloidosis patients 73 
Negative cardiac amyloidosis patients 197 
Total 270 
Next, we represented each patient as a vector using information from their EHRs stored in Northwestern Medicine 
Enterprise Data warehouse (NMEDW). Each patient record was then processed so that all relevant sections of the 
patient records which are potentially useful for creating features space were extracted. The relevant sections or 
feature types we have considered in this study are Demographics (such as Gender, Race, Ethnicity and Age), 
Diagnosis, Medication, Problems, Surgical data and Progress Notes. Demographics, Diagnosis and Medication, 
Problems and Surgical data are available in structured form, whereas Progress notes are only available as 
unstructured text. The value of each feature type is then transformed in order to be useful for machine learning 
classifier. Each value of Demographics, Diagnosis and Medication is treated as a binary feature. For example, if a 
patient has diagnosis “Anemia”, we assigned a vector for “Anemia” and assigned a value of 1 for that patient and 0 
for other patients. Similarly the presence of each medication such “Paracetamol” is treated as a separate feature. 
Certain variable such as ‘age’ in Demographics are numeric with a wide range of values. Such features are 
discretized14 by transforming the numbers to assignment in bins or ranges. That is, rather than representing the age 
of the patient by its numeric value (for e.g. 43), we represent it by a range (e.g. 40-49). Processing the records this 
way generated, 15 Demographics features, 5002 Diagnosis features, 3521 Medication features, 2124 Problem 
features and 101 Surgical data features. For transforming Progress notes to informative features, we follow the 
widely used Bag-of-Words model. The progress notes from all patient records are first preprocessed (lowercase, 
removal of punctuation and stop words, normalizing numeric values to placeholders) and then tokenized to unigrams 
and bigrams bag of words. These are then further pruned by ignoring the very high frequency unigrams or bigrams. 
After the transformation, in total, we get 1766 unigram features and 1044 bigram features for this dataset. The 
features are summarized in Table 2. 
Table 2. Feature types and number of features under each type 
Demographics Features 15 
Diagnosis Features 5002 
Medication Features 3521 
Problem Features 2124 
Surgical Features 101 
Unigram Features 1766 
Bigram Features 1044 
Total 13573 
On this dataset of 223 instances and 8011 features several machine learning classifiers which we describe next are 
trained. 
The machine learning classification algorithms we have considered in our study are K Nearest Neighbors,15,16 
Support Vector Machines,17,18 Decision Trees,19 Random Forests,20 AdaBoost,21 and Naïve Bayes22,23. K-nearest 
neighbors (KNN) is an instance based learning algorithm that stores all the training instances and classifies the new 
cases based on the distance functions. K-NN works on the principle of classifying the new test case by a majority 
vote, with the test case being assigned to the class most common amongst its K nearest neighbors. Each point in the 
neighborhood may be assigned equal importance or given some sort of weight such as distance (larger the distance 
smaller the weight/importance). 
Support Vector Machine (SVM) performs classification by finding the hyperplane that maximizes the margin 
between the two classes. The instances that define the hyperplane are called support vectors. SVM is high 
performing machine learning classifier due to the fact that if the data is linearly separable, SVM would produce a 
hyperplane that completely separates the vectors into two classes. However, in real life scenario perfect separation 
may not be possible. In such a case we can use different kernel function to project the data point into a different 
feature space where data may be linearly separable. Kernel function can be viewed as feature extraction techniques 
which take the existing features as input, performs the transformation and output a new feature space. 
Naïve Bayes (NB) algorithm is based on the Bayes theorem with assumption that the features are independent of 
each other. NB model is easy to develop with no parameter estimation. Despite its simplicity, NB model is widely 
used and outperforms other sophisticated machine learning algorithms such as SVM. NB provides a method of 
calculating posterior probability of class given the prior probability and learning the likelihood of features given the 
class.  
Decision trees (DT) builds classification models using a tree like structure. It works on the principle of divide and 
conquer breaking the dataset at each feature according to the best split and at the same time incrementally building 
the tree. The final result of the algorithm is a tree with decision node and leaf nodes. Decision node makes a certain 
conclusion depending upon the feature and has two or more branches. Leaf node does the final classification. 
Random Forest (RF) and AdaBoost are two ensemble algorithms which we have also used in our experiments. The 
principle behind working of RF algorithm is to construct many decision trees during the training and classifies the 
test case based on the mode of the classes given by individual trees. AdaBoost is another ensemble methods in 
which various other machine learning classifiers or also weak learners are combined to give a weighted sum that 
represents the output of the final classifier. It begins by fitting a classifier first on the data and then learning more 
classifiers by adjusting the weights of the previously misclassified data points. 
In addition, there are also a variety of hyper-parameters that were tuned in tandem for each of these classification 
algorithms. Table 3 lists the various algorithms and the corresponding hyper-parameters and their value ranges 
involved with each algorithm. We perform grid search24 technique which is a brute-force exhaustive method to 
search for the best parameters through the manually specified subset of the hyper-parameter space of a learning 
algorithm. 
Table 3. Classification Algorithms used, their hyper-parameters and range 
Classification Algorithm Hyper-parameter Range of Value searched over 
K-Nearest Neighbor K – Number of nearest neighbors 
Weights – weight of points in 
neighborhood 
K – {1, 2, 3} 
Weights – {Uniform, Distance} 
Support Vector Machines C – Loss regularization tradeoff 
Kernel – Kernel type  
Gamma – kernel coefficient 
C – {0.01, 0.1, 1, 10, 100} 
Kernel – {linear, rbf} 
Gamma – {1e-3, 1e-4} 
Naïve Bayes None  
Decision Trees Criterion – Quality measure of the split Criterion – {gini, entropy} 
Random Forests N-Estimator – Number of trees in forest 
Criterion – Quality measure of the split 
N-Estimator – {10, 15, 100} 
Criterion – {gini, entropy} 
AdaBoost N-Estimator – Maximum number of 
estimators  
N-Estimator – {10, 15, 100} 
In addition to various algorithms and models, we also employed feature selection methods to improve upon the 
accuracy of the classification models. First, features with very low variance are removed. That is, the features whose 
85% of values are either ‘0’ or ‘1’ are removed since they do not give much information about either category. We 
then used L1 regularization25 to do more feature selection and thereby identify top features to identify those that play 
decisive roles in classifying the patient into each category. L1 regularization adds a weight penalty to the loss 
function. Since each non-zero weight adds to the penalty, it forces weak features to have zero weight. Thus, this 
produces a sparse solution by intrinsically performing feature selection.  
To evaluate the system, we perform tenfold cross-validation and report the average F1 score26 (harmonic mean of 
precision and recall).  
Results 
Table 4. Optimal Parameters for each machine learning and average F1 score 
Algorithm Configuration Average 10 cross validation F1 score 
K Nearest Neighbor K – 1, criterion – ‘uniform’ 0.42 
Naïve Bayes  0.71 
SVM Kernel – rbf,  C -100, gamma - 
0.001 
0.93 
Decision Tree Criterion – gini 0.94 
Random Forest N-estimator - 15, Criterion – gini 0.94 
AdaBoost N-estimator - 15 0.97 
   
Table 4 shows the optimal configuration for each classification algorithm used as measured by average tenfold 
cross-validation F1 score. Since the number of positive instances in the dataset is very small, the number of nearest 
neighbors (KNN) take the least possible value 1 (K in KNN). KNN and NB gives a very low F1 score as compared 
to other complex algorithms since they are sensitive to outliers and also do not perform adequate feature selection. 
These algorithms give equal importance to all the features, which leads to poor performance. On the other hand, 
SVM, DT and Ensemble methods give a large F1-score due to complexity in models and ability to intrinsically 
performing feature selection. Also, as expected, ensemble method AdaBoost outperforms rest of the algorithms 
since it combines the output of other weak learners to arrive at the final hypothesis. 
Table 5. Top Features or Factors from feature selection 
Age range of 80-89 
Age range of 70-79 
Diagnosis of cardiac arrest 
Diagnosis of chest pain 
Diagnosis of congestive heart failure 
Diagnosis of hypertension 
Diagnosis of prim open angle glaucoma 
Diagnosis of shoulder arthritis 
Medication of  Doxercalciferol 
Medication of Loratadine 10mg 
Medication of Levothyroxine Sodium 25mcg 
Medication of 008278-ZZceFAZolin Sodium 
Medication of Sodium Chloride 0.9% 
 
We list some of the important features obtained after performing feature selection in Table 5. It can be seen that 
patients in age range 70-90 are more likely to have cardiac amyloidosis than patients of other ages. Also, presence of 
other cardiac diagnosis such as congestive heart failure and chest pain as important features shows that cardiac 
amyloidosis are comorbid with other heart problems. Some of the medications are also suggestive of this hypothesis. 
However, this requires further analysis and inputs from multiple cardiologists. 
The accuracy measures on re-running the machine learning algorithms using only the features filtered from feature 
selection technique are listed in Table 6. All the algorithms give nearly high and similar average cross-validation F1 
score. As anticipated, there is also rise in scores of KNN and NB due to removal of noisy insignificant features.  
Table 6. Accuracy Measures after feature selection 
Algorithm Average 10 cross validation F1 score 
K Nearest Neighbor 0.95 
Naïve Bayes 0.974 
SVM 0.976 
Decision Tree 0.974 
Random Forest 0.981 
AdaBoost 0.975 
Discussion 
This work is very relevant to an emerging direction in clinical informatics research focusing on developing patient 
similarity measures derived from EHR data for application in a variety of areas.27-36 For example, Zhang et al used 
patient similarity and drug similarity for personalized medicine.35 Wang et al attempted to implement treatment 
recommendations and Sanders et al used similarity measure for visualizing which patients are similar.27,28 Li et al 
used topological similarity measures to identify subgroups of type 2 diabetes patients.31 Huang et al applied such 
metrics for analyzing clinical pathways and Lee et al and Ng et al applied for predicting mortality for individual 
patients.32,36 There are systems such as PSF that are evaluating novel metric learning approaches and those that are 
using external knowledge resources such as PubMed to improved patient similarity measures.33,34  
 
We also used Apache cTAKES37 to extract more features from unstructured Progress notes. However, since we are 
already accomplishing a very high average cross-validation F1 score and the unigram and bigram features that are 
also obtained from progress notes are not very predictive, we decided not to currently use them in further 
experiments. These would have only further escalated the curse of dimensionality38 and will not have contributed 
significantly to increase the accuracy of the models.  However, we might implement NLP-based features as we are 
expanding our algorithm to other rare diseases. 
 
In spite of the high accuracy of our system, there is a limitation. In our training set, the instances are moderately 
balanced, i.e., positive and negative instances are 1:3 in ratio. However, as we have mentioned in the Introduction, 
cardiac amyloidosis is a rare disease. The ratio in real scenario will be closer to 1:1000. If we directly use the models 
produced through our methods, we may get a large number of false positives and thereby low precision rate because 
of failure to generalize and the sample data not being true representative of real world data39. To counter this, we 
need to do preprocessing using high recall rules to filter out the very obvious negative instances. The goal of these 
rules will be to reduce the skewness of the real world data. After the filtering step, our models can be applied on the 
resulting dataset. These high recall rules can be implemented using the factors identified through our methods as 
most predictive in Table 5. We can also employ other feature selection techniques such as wrapper methods, tree 
based induction methods40 or use association mining41,42 for doing. We consider this beyond the scope of this initial 
work.  
Conclusion 
We have developed a machine learning system to automatically identify cardiac amyloidosis patients using EHR 
data. We performed data processing, parameter estimation, feature selection and model selection to achieve a very 
high tenfold cross-validation F1 score of 0.98 using Random Forest, an ensemble machine learning classifier. We 
have also reported some of the most predictive features. However, our system needs to be validated for its 
operational value across an entire healthcare system by executing it on system-wide EHR data for identifying rare 
disease patients and manually verifying the accuracy.  
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